CVS Health Corporation
MX ˙ BMV ˙ US1266501006
SecurityMX:CVS / CVS Health Corporation
InstitutionHartland & Co., LLC
Latest Disclosed Ownership37,925 shares
Latest Disclosed Value $ 2,723,763
Hartland & Co., LLC reports 6.51% increase in ownership of CVS / CVS Health Corporation

On May 6, 2026 - Hartland & Co., LLC filed a 13F-HR form disclosing ownership of 37,925 shares of CVS Health Corporation (MX:CVS) valued at $2,723,763 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 35,606 shares of CVS Health Corporation. This represents a change in shares of 6.51% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F CVS HEALTH COM 126650100 37,925 2,319 6.51 2,724 -3.61 0.0249
2026-02-09 2025-12-31 13F CVS HEALTH COM 126650100 35,606 -874 -2.40 2,826 2.73 0.0356
2025-11-10 2025-09-30 13F CVS HEALTH COM 126650100 36,480 18,538 103.32 2,750 122.31 0.0361
2025-08-08 2025-06-30 13F CVS HEALTH COM 126650100 17,942 1,437 8.71 1,238 10.64 0.0174
2025-05-13 2025-03-31 13F CVS HEALTH COM 126650100 16,505 3,950 31.46 1,118 98.58 0.0173
2025-02-10 2024-12-31 13F CVS HEALTH COM 126650100 12,555 -32,632 -72.22 564 -80.18 0.0086
2024-11-13 2024-09-30 13F CVS HEALTH COM 126650100 45,187 -270 -0.59 2,841 5.85 0.0441
2024-08-12 2024-06-30 13F CVS HEALTH COM 126650100 45,457 19,452 74.80 2,685 82.83 0.0458
2024-05-14 2024-03-31 13F CVS HEALTH COM 126650100 26,005 1,241 5.01 1,469 -24.91 0.0727
2024-02-12 2023-12-31 13F CVS HEALTH COM 126650100 24,764 4,186 20.34 1,955 36.14 0.1038
2023-11-13 2023-09-30 13F/A-1 CVS HEALTH COM 126650100 20,578 1,195 6.17 1,437 7.24 0.0883
2023-11-07 2023-09-30 13F CVS HEALTH COM 126650100 21,347 1,964 1,490 0.0820
2023-08-07 2023-06-30 13F CVS HEALTH COM 126650100 19,383 2,773 16.69 1,340 8.51 0.0812
2023-05-09 2023-03-31 13F CVS HEALTH COM 126650100 16,610 -5,565 -25.10 1,234 -40.27 0.0898
2023-02-14 2022-12-31 13F CVS HEALTH COM 126650100 22,175 1,206 5.75 2,067 3.30 0.1619
2022-11-15 2022-09-30 13F CVS HEALTH COM 126650100 20,969 -163 -0.77 2,000 2.15 0.1843
2022-08-12 2022-06-30 13F CVS HEALTH COM 126650100 21,132 5,815 37.96 1,958 26.32 0.1526
2022-05-04 2022-03-31 13F CVS HEALTH COM 126650100 15,317 2,600 20.45 1,550 18.14 0.1052
2022-02-14 2021-12-31 13F CVS HEALTH COM 126650100 12,717 1,121 9.67 1,312 33.33 0.0892
2021-11-12 2021-09-30 13F CVS HEALTH COM 126650100 11,596 -308 -2.59 984 -0.91 0.0734
2021-08-12 2021-06-30 13F CVS HEALTH COM 126650100 11,904 581 5.13 993 16.55 0.0764
2021-05-14 2021-03-31 13F CVS HEALTH COM 126650100 11,323 393 3.60 852 14.21 0.0710
2021-02-11 2020-12-31 13F CVS HEALTH COM 126650100 10,930 -502 -4.39 746 11.68 0.0678
2020-11-12 2020-09-30 13F CVS HEALTH COM 126650100 11,432 -912 -7.39 668 -16.71 0.0716
2020-08-11 2020-06-30 13F CVS HEALTH COM 126650100 12,344 1,725 16.24 802 27.30 0.0927
2020-05-14 2020-03-31 13F CVS HEALTH COM 126650100 10,619 -2,437 -18.67 630 -35.05 0.0917
2020-02-11 2019-12-31 13F CVS HEALTH COM 126650100 13,056 321 2.52 970 20.80 0.1177
2019-11-12 2019-09-30 13F CVS HEALTH COM 126650100 12,735 -246 -1.90 803 13.58 0.1075
2019-08-08 2019-06-30 13F CVS HEALTH COM 126650100 12,981 -2,347 -15.31 707 -14.51 0.0942
2019-05-14 2019-03-31 13F CVS HEALTH COM 126650100 15,328 -892 -5.50 827 -22.20 0.1141
2019-02-08 2018-12-31 13F CVS HEALTH COM 126650100 16,220 3,134 23.95 1,063 3.20 0.1656
2018-11-13 2018-09-30 13F CVS HEALTH COM 126650100 13,086 -122 -0.92 1,030 21.18 0.1412
2018-08-07 2018-06-30 13F CVS HEALTH COM 126650100 13,208 -778 -5.56 850 -2.30 0.1212
2018-05-14 2018-03-31 13F CVS HEALTH COM 126650100 13,986 1,557 12.53 870 -3.44 0.1261
2018-02-09 2017-12-31 13F CVS HEALTH COM 126650100 12,429 -6,229 -33.39 901 -40.61 0.1221
2017-11-09 2017-09-30 13F CVS HEALTH COM 126650100 18,658 -1,388 -6.92 1,517 -5.95 0.1976
2017-08-03 2017-06-30 13F CVS HEALTH COM 126650100 20,046 1,375 7.36 1,613 10.03 0.2356
2017-05-11 2017-03-31 13F CVS HEALTH COM 126650100 18,671 619 3.43 1,466 2.95 0.2130
2017-02-10 2016-12-31 13F CVS HEALTH COM 126650100 18,052 18,052 1,424 0.2304
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.